S
Sergio Neri
Researcher at University of Catania
Publications - 110
Citations - 3131
Sergio Neri is an academic researcher from University of Catania. The author has contributed to research in topics: Hepatitis C & Hepatitis. The author has an hindex of 28, co-authored 109 publications receiving 2685 citations.
Papers
More filters
Journal ArticleDOI
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial.
Paolo Caraceni,Oliviero Riggio,Paolo Angeli,Carlo Alessandria,Sergio Neri,Francesco Giuseppe Foschi,F. Levantesi,Aldo Airoldi,S. Boccia,Gianluca Svegliati-Baroni,Stefano Fagiuoli,Roberto Giulio Romanelli,Raffaele Cozzolongo,Vito Di Marco,Vincenzo Sangiovanni,Filomena Morisco,Pierluigi Toniutto,Annalisa Tortora,Rosanna De Marco,Mario Angelico,Irene Cacciola,Gianfranco Elia,Alessandro Federico,Sara Massironi,Riccardo Guarisco,Alessandra Galioto,Giorgio Ballardini,Maria Rendina,Silvia Nardelli,Salvatore Piano,Chiara Elia,Loredana Prestianni,Federica Mirici Cappa,Lucia Cesarini,L. Simone,Chiara Pasquale,M. Cavallin,Alida Andrealli,F. Fidone,Matteo Ruggeri,A. Roncadori,Maurizio Baldassarre,Manuel Tufoni,Giacomo Zaccherini,Mauro Bernardi,Marco Domenicali,Ferdinando Giannone,Manuela Merli,Stefania Gioia,Silvano Fasolato,Antonietta Sticca,Daniela Campion,A. Risso,Giorgio Maria Saracco,D. Maiorca,Agostino Rizzotto,Arianna Lanzi,Elga Neri,Anna Visani,Antonio Mastroianni,A Alberti,Chiara Mazzarelli,Marcello Vangeli,Marco Marzioni,Francesca Capretti,Alba Kostandini,G. Magini,M. Colpani,Giacomo Laffi,T Gabbani,Maria Marsico,M. Zappimbulso,Josè Petruzzi,Vincenza Calvaruso,Giovanni Parrella,Nicola Caporaso,Francesco Auriemma,Maria Guarino,Fabio Pugliese,Antonio Gasbarrini,Pietro Leo,Francesco De Leonardis,A. Pecchioli,Piera Rossi,Giovanni Raimondo,Elisa Negri,Marcello Dallio,Carmelina Loguercio,Dario Conte,Natascia Celli,R. Bringiotti,N.M. Castellaneta,Francesco Salerno +92 more
TL;DR: Long-term HA administration prolongs overall survival and might act as a disease modifying treatment in patients with decompensated cirrhosis in this trial.
Journal ArticleDOI
Hepatitis C infection, antiviral treatment and mental health: a European expert consensus statement.
Martin Schaefer,Lucile Capuron,Astrid Friebe,Crisanto Diez-Quevedo,Geert Robaeys,Sergio Neri,Graham R. Foster,Achim Kautz,Daniel M. Forton,Carmine M. Pariante +9 more
TL;DR: The summarised current knowledge about mental health changes before and during antiviral treatment should improve interdisciplinary management of HCV infected patients.
Journal ArticleDOI
Terlipressin and Albumin in Patients with Cirrhosis and Type I Hepatorenal Syndrome
Sergio Neri,Pulvirenti D,Mariano Malaguarnera,Bruno M. Cosimo,Gaetano Bertino,Luca Ignaccolo,Sebasiano Siringo,Pietro Castellino +7 more
TL;DR: It seems to confirm that the administration of terlipressin plus albumin improves renal function in patients with cirrhosis and type I HRS and that a reversal of hepatorenal syndrome is strongly associated with improved survival.
Journal ArticleDOI
Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor
Hilary Longhurst,Marco Cicardi,Timothy J. Craig,Konrad Bork,Clive Grattan,James R. Baker,H. Li,Avner Reshef,James R. Bonner,Jonathan A. Bernstein,John Anderson,William R. Lumry,Henriette Farkas,Constance H. Katelaris,Gordon Sussman,Joshua J. Jacobs,Marc A. Riedl,Michael E. Manning,Jacques Hébert,Paul K. Keith,Shmuel Kivity,Sergio Neri,Donald Levy,Maria L. Baeza,Robert A. Nathan,Lawrence B. Schwartz,Teresa Caballero,William H. Yang,Ioana Crisan,Maria Dolores Hernandez,I. Hussain,M. D. Tarzi,Bruce Ritchie,Pavlína Králíčková,Mar Guilarte,Syed M. Rehman,Aleena Banerji,Richard G. Gower,Debra M. Bensen-Kennedy,Jonathan M. Edelman,Henrike Feuersenger,John-Philip Lawo,Thomas Machnig,Dipti Pawaskar,Ingo Pragst,Bruce L. Zuraw +45 more
TL;DR: In patients with hereditary angioedema, the prophylactic use of a subcutaneous C1 inhibitor twice weekly significantly reduced the frequency of acute attacks.
Journal ArticleDOI
Oxidative stress, glutathione status, sirtuin and cellular stress response in type 2 diabetes.
Vittorio Calabrese,Carolin Cornelius,Veruscka Leso,Veruscka Leso,A. Trovato-Salinaro,B. Ventimiglia,M. Cavallaro,Maria Scuto,S. Rizza,Luca Zanoli,Sergio Neri,Pietro Castellino +11 more
TL;DR: Patients affected by type 2 diabetes are under condition of systemic oxidative stress and, although the relevance of downregulation in sirtuin signal has to be fully understood, however induction of HSPs and thioredoxin protein system represent a maintained response in counteracting systemic pro-oxidant status.